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ORIGINAL ARTICLE

Determinants and Impact of Giardia Infection in the First
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Background. Giardia are among the most common enteropathogens detected in children in low-resource settings. We describe
here the epidemiology of infection with Giardia in the first 2 years of life in the Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and the Consequences for Child Health and Development Project (MAL-ED), a multisite birth-cohort
study.
Methods. From 2089 children, 34 916 stool samples collected during monthly surveillance and episodes of diarrhea were tested
for Giardia using an enzyme immunoassay. We quantified the risk of Giardia detection, identified risk factors, and assessed the
associations with micronutrients, markers of gut inflammation and permeability, diarrhea, and growth using multivariable linear
regression.
Results. The incidence of at least 1 Giardia detection varied according to site (range, 37.7%–96.4%) and was higher in the second year of life. Exclusive breastfeeding (HR for first Giardia detection in a monthly surveillance stool sample, 0.46 [95% confidence
interval (CI), 0.28–0.75]), higher socioeconomic status (HR, 0.74 [95% CI, 0.56–0.97]), and recent metronidazole treatment (risk
ratio for any surveillance stool detection, 0.69 [95% CI, 0.56–0.84]) were protective. Persistence of Giardia (consecutive detections)
in the first 6 months of life was associated with reduced subsequent diarrheal rates in Naushahro Feroze, Pakistan but not at any
other site. Giardia detection was also associated with an increased lactulose/mannitol ratio. Persistence of Giardia before 6 months
of age was associated with a −0.29 (95% CI, −0.53 to −0.05) deficit in weight-for-age z score and −0.29 (95% CI, −0.64 to 0.07) deficit
in length-for-age z score at 2 years.
Conclusions. Infection with Giardia occurred across epidemiological contexts, and repeated detections in 40% of the children
suggest that persistent infections were common. Early persistent infection with Giardia, independent of diarrhea, might contribute
to intestinal permeability and stunted growth.
Keywords. children; Giardia; growth; intestinal permeability; risk factors.
INTRODUCTION

Giardia lamblia, also known as Giardia duodenalis and Giardia
intestinalis, is the most common etiology of intestinal parasitic infection in the first 2 years of life in low-resource settings.
Although Giardia is a recognized pathogen of waterborne diarrhea outbreaks [1] and a common cause of diarrhea among travelers [2–4] and after recreational water exposure [5], the impact
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of endemic pediatric giardiasis is less clear. Two large studies
of global etiologies of endemic pediatric diarrhea, the Global
Enterics Multicenter Study (GEMS) [6] and the Etiology, Risk
Factors, and Interactions of Enteric Infections and Malnutrition
and the Consequences for Child Health and Development Project
(MAL-ED) [7], found Giardia significantly more often in nondiarrheal than diarrheal stools. Similarly, Giardia was not associated
with acute diarrhea in a meta-analysis of 12 acute pediatric diarrhea studies [4], and Giardia had a protective effect against acute
diarrhea in 2 longitudinal studies [8, 9].
Evidence for an association between Giardia infection and
child growth outcomes has been mixed [10–15]. Giardia infection is associated with disrupted villus architecture [16], an
elevated lactulose/mannitol ratio (a marker of intestinal permeability) [17, 18], and zinc and vitamin A deficiencies [19–21],
which suggests gut dysfunction and inadequate nutrient uptake.
These associations, however, have been inconsistent and limited
Giardia Epidemiology and Impact • JPIDS 2017:6 (June) • 153

in ascribing directionality, because vitamin A deficiency, for
example, can increase susceptibility to Giardia infection [22].
The multisite MAL-ED birth-cohort study [23] provides
high-resolution prospective data to clarify early-life Giardia
epidemiology in high-prevalence settings. Longitudinal analysis specifically enables assessment of the temporality between
detection of Giardia, diarrhea, micronutrient status, markers of
intestinal permeability and inflammation, and the estimation
of longer-term effects on growth. Here, we describe the determinants, burden, and impact of Giardia infection in the first
2 years of life in 8 low-resource sites.
METHODS

The MAL-ED study design and methods have been described
[23]. In brief, the study was conducted between November
2009 and February 2014 at sites in Dhaka, Bangladesh (BGD),
Fortaleza, Brazil (BRF), Vellore, India (INV), Bhaktapur, Nepal
(NEB), Naushahro Feroze, Pakistan (PKN), Loreto, Peru (PEL),
Venda, South Africa (SAV), and Haydom, Tanzania (TZH).
Children were followed from birth (<17 days of age) via twiceweekly home visits for illness surveillance, medicines, and
breastfeeding practices and monthly for anthropometry until
they reached 2 years of age [24]. Nondiarrheal surveillance
stool samples were collected and tested for 40 enteropathogens
[25] monthly in the first year (0–12 months) of life and quarterly in the second year (12–24 months) of life. Stool samples
were collected and tested also during every diarrhea episode
reported during the twice-weekly surveillance visits. Diarrhea
was defined as maternal report of 3 or more loose stools in 24
hours or 1 stool with visible blood [24]. Weight-for-age (WAZ)
and length-for-age (LAZ) z scores were calculated using the
2006 World Health Organization child growth standards [26].
Sociodemographic information was assessed biannually and
summarized using the Water, Assets, Maternal Education,
Income (WAMI) score, which is based on monthly household
income, maternal education, wealth measured by 8 assets, and
access to improved water and sanitation [27], as defined by
World Health Organization guidelines [28]. Plasma zinc and retinol concentrations were assessed at 7, 15, and 24 months of age
[29]. Urinary lactulose/mannitol excretion ratios, measured at
3, 6, 9, and 15 months of age, were converted into sample-based
z scores (LMZs) using the BRF cohort as the internal reference
population [30]. All sites received ethical approval from their
respective governmental, local institutional, and collaborating
institutional ethical review boards. Informed written consent
was obtained from the parent or guardian of each child.
Data and Definitions

We included in the analysis all monthly surveillance and diarrheal stool samples that were tested for Giardia by enzyme
immunoassay (EIA) (TechLab, Blacksburg, VA), the majority of
154 • JPIDS 2017:6 (June) • Rogawski et al

which were also tested by wet-prep microscopy. The laboratory
methods for detecting other enteropathogens and gut biomarkers, including α-1-antitrypsin (ALA), myeloperoxidase (MPO),
neopterin (NEO), and α-1-acid glycoprotein (AGP), a marker
of systemic inflammation, have been described [25, 29, 31].
Definitions of incident Giardia-related diarrhea were defined
with increasing specificity for diarrhea of true Giardia etiology
as follows: (1) Giardia-positive diarrhea, Giardia was detected
in a diarrheal stool sample; (2) new Giardia-positive diarrhea, Giardia was detected in a diarrheal stool sample, and the
most recent previous stool sample tested negative for Giardia
or was taken more than 2 months earlier; (3) Giardia-positive
diarrhea-associated pathogens–negative diarrhea, Giardia was
detected in a diarrheal stool sample, but no diarrhea-associated
pathogens that were previously identified in MAL-ED were
detected (13 of 40 pathogens tested, ie, norovirus GII, rotavirus, astrovirus, adenovirus, Campylobacter, Cryptosporidium,
heat-stable enterotoxin-producing enterotoxigenic Escherichia
coli, typical enteropathogenic E coli, heat-labile enterotoxin-producing enterotoxigenic E coli, Shigella, enteroinvasive E
coli, Entamoeba histolytica, and Salmonella [7]); and (4) Giardiapositive-only diarrhea, Giardia was detected in a diarrheal stool
sample, and no other enteropathogens among all 40 tested were
detected [25]. Persistence of Giardia detection was defined as
2 consecutive stool samples that tested positive for Giardia (2
consecutive months in the first year of life or 2 consecutive
quarters in the second year). Prolonged persistence was defined
as 3 consecutive stool samples that tested positive for Giardia.
Data Analysis

Risk factors for the first detection of Giardia in surveillance
stool samples were identified using pooled logistic regression
to estimate hazard ratios (HRs) and adjusting for site and a
restricted quadratic spline [32] for age. Variables in the multivariable model were included on the basis of statistical significance, model fit by the quasi-likelihood information criterion,
covariance between factors, and variability of factors within sites
for site-specific models. Comparing by the Akaike information
criterion (AIC) to models with linear week of the year, seasonality was assessed by modeling Giardia detection with linear,
quadratic, and cubic terms for the week of the year (w), and the
terms sin(2πw/52), cos(2πw/52), sin(4πw/52), and cos(4πw/52).
We used Poisson regression to evaluate associations between
zinc and vitamin A status with Giardia detection in surveillance stool samples and adjusted for previous Giardia detection
and potential confounders included in the multivariable risk
factor model. We estimated the effect of Giardia detection on
subsequent diarrheal rates using pooled logistic regression with
general estimating equations (GEEs) and robust variance to
account for correlation between outcomes within children and
adjusted for the same confounders and illness symptoms during
the exposure periods. We estimated the effect of Giardia in all

stools on gut biomarker concentrations using multivariable
linear regression with GEEs and adjusted for stool consistency
and presence of the 2 other pathogens of highest prevalence,
enteroaggregative E coli (EAEC) and Campylobacter. Last, we
estimated the effect of Giardia detection in surveillance stools
on WAZ and LAZ attainment at 2 years of age using multivariable linear regression with GEEs. Confounders, listed in the
table footnotes, included baseline sociodemographic characteristics associated with Giardia detection identified above and
EAEC and Campylobacter stool positivity. Data from SAV were
excluded from zinc-related analyses and data from PKN were
excluded from length-related analyses because of measurement
quality concerns at those sites. For analyses limited to surveillance stool samples, results (not shown) were consistent when
we repeated analyses with diarrheal stool samples.
RESULTS
Diagnostics

Of 34 916 stool samples (27 092 surveillance and 7824 diarrheal)
tested for Giardia by an EIA, 33 796 (96.8%) were also tested for
Giardia by wet-prep microscopy. Compared to EIA, the sensitivity of microscopy was 46.2%, and its specificity was 99.3%.
Giardia positivity by microscopy was 21% less likely if the stool
was watery or liquid than if it was soft or formed (risk ratio
[RR], 0.79 [95% confidence interval (CI), 0.68–0.90]), but we
found no association between stool consistency and EIA results
(RR, 0.94 [95% CI, 0.86–1.03]).
Incidence and Persistence

Among 2089 children with at least 1 tested stool, the overall
Giardia prevalence according to the EIA in stool samples was
14.7% (n = 5135). Giardia was detected at least once in twothirds (n = 1178) of the 1741 children followed to 2 years of age

(range, 37.7% [BRF] to 96.4% [PKN]). The overall median times
to Giardia detection, which varied according to site, were 18.0
and 20.0 months for surveillance and diarrheal stool samples,
respectively (Figure 1).
The incidence of Giardia-positive diarrhea was 40.4 cases
per 100 person-years. However, measures of Giardia-related
diarrhea incidence decreased by approximately 60%, 75%, and
more than 80% when we required the previous stool sample
to have tested negative for Giardia, the current stool sample to
have no detection of diarrhea-associated pathogens, and the
current stool sample to have no detection of any other pathogens, respectively (Table 1).
The overall prevalence of Giardia detected in surveillance
stool samples was 13.6% (Table 1). However, the prevalence
decreased by more than half (6.0%) when we required the previous surveillance stool to have tested negative for Giardia.
Repeated Giardia detections in surveillance stool samples
occurred in 838 (40.1%) children (Supplementary Figure 1).
The prevalence of persistence was less than 5% before 6 months
of age in all except the PKN site but increased to 31.8% overall
in the second year of life.
Risk Factors

Giardia detection increased with age over the first 2 years of life;
a 1-month increase in age was associated with an 11% increase in
the risk of Giardia detection in surveillance stool samples (RR, 1.11
[95% CI, 1.10–1.12]). The percentage of days in the previous month
that the child was exclusively breastfed was a strongly protective
factor against first Giardia detection (Table 2). Socioeconomic
factors, including increased socioeconomic score (Water, Assets,
Maternal Education, Income score [27]), household income, and
older maternal age, were also protective. Metronidazole exposure
in the previous 15 days was associated with a 31% relative decrease
(95% CI, 16–44) in Giardia detection in surveillance stool samples,

Figure 1. Cumulative incidence of Giardia detection in surveillance and diarrheal stool samples across all sites (A) and in surveillance stool samples within
each site (B) among 2089 children in the Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health
and Development Project (MAL-ED) cohort with at least 1 stool tested for Giardia.
Giardia Epidemiology and Impact • JPIDS 2017:6 (June) • 155

Table 1. Prevalence of Giardia Detection in Surveillance Stools and Incidence of Giardia-Related Diarrhea According to Site Among 2089 Children in
the MAL-ED Birth Cohort
Prevalence (%) of Giardia Detection
in Monthly Surveillance Stools

Incidencea of GiardiaPositive Diarrhea

Incidencea of New GiardiaPositive Diarrheab

Site

Incidencea of Giardia-Positive DiarrheaAssociated Pathogens–Negative
Diarrheac

Incidencea of Giardia-PositiveOnly Diarrhead

BGD

4.2

22.8 (18.7–27.7)

12.3 (9.4–16.1)

1.8 (0.9–3.6)

1.4 (0.6–3.0)

BRF

7.3

4.6 (2.9–7.4)

1.8 (0.9–3.8)

1.5 (0.7–3.4)

1.0 (0.4–2.8)

INV

13.1

21.4 (17.6–26.1)

8.1 (5.9–11.2)

6.6 (4.6–9.4)

4.4 (2.8–6.8)

NEB

9.2

18.2 (14.6–22.6)

7.5 (5.4–10.5)

6.6 (4.6–9.5)

5.1 (3.4–7.7)

PEL

16.4

115.8 (106.3–126.2)

40.4 (34.9–46.7)

28.7 (24.1–34.0)

18.7 (15.1–23.2)

PKN

35.2

126.2 (116.3–136.9)

42.5 (36.9–48.9)

28.3 (23.8–33.6)

15.7 (12.4–19.7)

SAV

6.4

4.1 (2.6–6.3)

2.4 (1.4–4.3)

1.0 (0.4–2.4)

0.61 (0.20–1.9)

TZH

16.2

7.0 (5.0–9.9)

3.7 (2.3–6.0)

0.44 (0.11–1.8)

0.22 (0.03–1.6)

All

13.6

40.4 (38.4–42.5)

15.0 (13.8–16.3)

9.5 (8.5–10.5)

5.9 (5.2–6.8)

Abbreviations: BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; NEB, Bhaktapur, Nepal; PEL, Loreto, Peru; PKN, Naushahro Feroze, Pakistan; SAV, Venda, South Africa; TZH, Haydom, Tanzania.
a
Rate per 100 person-years.
b
New Giardia-positive diarrhea was defined if Giardia was detected in the diarrheal stool and the most recent previous stool tested negative for Giardia or was taken more than 2 months earlier (n = 539 of 1452 [37.1%] of all
Giardia-positive diarrheal stools).
c
Giardia-positive diarrhea-associated pathogens–negative diarrhea was defined if Giardia was detected in the diarrheal stool and no diarrhea-associated pathogens were detected (n = 341 of 1291 [26.4%] of all completely tested
Giardia-positive diarrheal stools). Diarrhea-associated pathogens (norovirus GII, rotavirus, astrovirus, adenovirus, Campylobacter, Cryptosporidium, heat-stable enterotoxin-producing enterotoxigenic E coli, typical enteropathogenic E coli, heat-labile enterotoxin-producing enterotoxigenic E coli, Shigella, enteroinvasive E coli, E. histolytica, and Salmonella) were associated with diarrhea in the first or second year of life [7].
d
Giardia-positive-only diarrhea was defined if Giardia was detected in the diarrheal stool and no other pathogens were detected (n = 214 of 1291 [16.6%] of all completely tested Giardia-positive diarrheal stool samples).

but we found no association with exposure more than 15 days earlier or with exposure to any other antibiotics.
Multiple hygiene and environmental risk factors were associated with Giardia detection. Hand-washing, treatment of drinking water, and increased water access were protective, whereas
the presence of siblings was a strong risk factor. Associations
with having a dirt floor and owning chickens indicate the
importance of environmental exposure to Giardia (Table 2). The
distribution of environmental factors differed according to site,
and although risk factor trends were generally consistent, there
were site-to-site variations in the magnitude and even the direction of associations in some cases (Supplementary Figure 2).
Giardia was positively correlated with Campylobacter detection (Pearson correlation coefficient [PCC], 0.15; P < .0001)
but not with the detection of EAEC (PCC, −0.02; P = .0001) or
viruses (PCC, −0.00; P = .7) in all stool samples, which suggests that the routes of transmission and/or age-susceptibility
patterns are similar to those of Campylobacter.
Seasonality

We found a significant increase in first Giardia detections in
surveillance stool samples in July through September and a
smaller peak in March/April in the south Asian sites (BGD,
INV, NEB, and PKN) (Supplementary Figure 3). Giardia seasonality was variable at the other sites, with peaks in December/
January in the BRF and PEL sites and a small peak in March/
April in the TZH and SAV sites. In contrast, we found no
evidence of seasonality when we included all Giardia detections. No association between site-specific mean temperature
or rainfall and Giardia positivity was found. The seasonality
of Giardia detection in diarrheal stool samples matched the
seasonality of all-cause diarrhea, which suggests that many
156 • JPIDS 2017:6 (June) • Rogawski et al

Giardia-positive diarrheal episodes were caused by other
pathogens (not shown).
Zinc, Vitamin A, and Giardia

Higher plasma zinc and retinol concentrations at 7 months of
age were associated with decreased subsequent Giardia detection (Supplementary Table 1). A combined 1 standard deviation
greater zinc and retinol concentration was associated with an
adjusted 22% (95% CI, 2%–37%) lower Giardia-detection rate in
surveillance stool samples from 8 to 24 months of age. A higher
retinol concentration at 15 months of age was also associated with
an approximate 10% decrease in the subsequent Giardia-detection
rate. There were no associations between zinc status and Giardia
detection at 15 months of age and no associations at either time
period between zinc or vitamin A status and incidence of Giardiapositive diarrhea.
Giardia detection in surveillance stool samples in the period
between vitamin A status measurements at 7 and 15 months
was associated with an adjusted −1.58 mg/dL (95% CI, −2.82
to −0.34 mg/dL) change in retinol concentration over that time
period. There were no associations between Giardia and change
in zinc concentration.
Giardia and Risk of Acute Diarrhea

Giardia detection in surveillance stool samples was not associated with short-term diarrheal risk (adjusted RR for diarrhea in
the following 30 days, 1.07 [95% CI, 0.96–1.19]). In addition, the
apparent negative association between Giardia detection and diarrhea previously reported (RR adjusted for age and site, 0.90 [95%
CI, 0.86–0.95]) [7] might be explained by treatment of 37% of all
diarrhea episodes with metronidazole, such that Giardia might
have been cleared before the diarrheal stool was collected. When

Table 2. Risk Factors for First Giardia Detection in Monthly Surveillance
Stool Samples Among 2088 Children in the MAL-ED Cohort With at Least 1
Surveillance Stool

Risk Factor

Semi-Univariable
(HR [95% CI])a

Multivariable
(HR [95% CI])b

Child characteristics
Female (vs male)

1.02 (0.89–1.16)

Enrollment weight
(per 1 z score)

1.05 (0.98–1.12)

Exclusively breastfed since birth

0.67 (0.37–1.20)

Percent days exclusively breastfed
in last month (100% vs 0%)

0.43 (0.27–0.70)

0.46 (0.28–0.75)
0.97 (0.91–1.03)

WAZ (per 1 z score)c

0.94 (0.88–1.00)

LAZ (per 1 z score)c,d

0.96 (0.89–1.03)

WLZ (per 1 z score)c,d

0.94 (0.88–1.00)

Metronidazole used in
previous 15 days

0.69 (0.47–1.01)

Metronidazole used in
previous 16–30 days

1.02 (0.73–1.42)

Associations With Gut-Function Biomarkers
0.71 (0.48–1.04)

Sociodemographic
Socioeconomic score
(WAMI [27], per 0.5 unit)

0.54 (0.42–0.69)

Household income at or above
site-specific median income

0.79 (0.69–0.91)

Maternal age (per 5 y)

0.83 (0.75–0.93)

Maternal education
(≥6 y completed)

0.74 (0.64–0.86)

Mother married

1.24 (0.95–1.60)

Child has siblings

1.36 (1.18–1.57)

Mean no. of people per room
in the household (per 1 unit)

1.09 (1.04–1.16)

Giardia detection was not associated with subsequent diarrheal rates in any except the PKN site (Supplementary Table 2).
Giardia persistence before 6 months of age was common at
the PKN site (17.4%) and was associated with an adjusted 28%
relative decrease (95% CI, 11–41]) in diarrheal rates from 6 to
24 months of age. Giardia persistence in the first year of life
at the PKN site (47.7%) was also associated with an adjusted
decrease in subsequent diarrheal rates (adjusted incidence rate
ratio, 0.81 [95% CI, 0.64–1.03]). The protective effect was driven
largely by protection against subsequent diarrhea in which
enteropathogenic bacteria were detected.

0.74 (0.56–0.97)

0.86 (0.77–0.96)

1.26 (1.09–1.46)

The presence of Giardia in stool samples was associated with
an elevated marker of increased intestinal permeability, LMZ,
across sites (Table 3), as indicated by an average increase in lactulose (z-score difference, 0.12 [95% CI, −0.00 to 0.24]) and a
decrease in mannitol (z-score difference, −0.15 [95% CI, −0.26
to −0.04]). We found no significant differences in the associations across ages, although the magnitude was greatest in the
second year of life (adjusted LMZ difference at 15 months, 0.25
[95% CI, 0.10–0.40]). Among markers of inflammation, Giardia
was also associated with a decrease in NEO concentration
(Table 3) but not consistently with MPO, ALA, or AGP.
Effects on Growth

Water
Improved (vs unimproved)
drinking water [28]

0.95 (0.72–1.25)

Time to access water (>10 min)

1.18 (0.97–1.44)

Treated (vs untreated) water

0.69 (0.54–0.88)

0.78 (0.61–1.00)

Sanitation and hygiene
Improved (vs unimproved)
sanitation [28]

0.89 (0.71–1.10)

Always washed hands after
child defecated

0.79 (0.71–0.89)

Always washed hands
before preparing food

0.85 (0.77–0.95)

Always washed hands
after using toilet

0.82 (0.73–0.92)

Used toilet paper

0.86 (0.76–0.98)

Shared toilet facility

1.10 (0.89–1.35)

0.80 (0.68–0.95)

0.95 (0.83–1.08)

Environmental
Dirt floor

1.34 (1.10–1.62)

Household owned cows

1.04 (0.80–1.35)

Household owned chickens

1.38 (1.12–1.70)

1.13 (0.92–1.38)
1.35 (1.10–1.66)

Abbreviations: CI, confidence interval; HR, hazard ratio; LAZ, length-for-age z score; WAMI, Water, Assets,
Maternal Education, Income; WAZ, weight-for-age z score; WLZ, weight-for-length z score.
a
Adjusted for site and age only (using restricted quadratic splines).
b
Adjusted for site, age, and all other variables with estimates in this column (significant or strong association
with Giardia detection in semi-univariable analysis, and not collinear with other variables).
c
At most recent measurement before stool collection.
d
Excluding PKN.

we adjusted for recent metronidazole exposure, the association
between Giardia detection and diarrhea moved toward the null
(RR, 0.95 [95% CI, 0.90–1.00]).

Giardia detection was associated with reduced weight and length
attainment at 2 years of age (Table 4). Compared with those with
low Giardia exposure (the 10th percentile of Giardia positivity in
surveillance stool samples over the first 2 years of life), children
with high exposure (the 90th percentile of Giardia positivity)
had an adjusted −0.12 LAZ decrement (95% CI, −0.25 to 0.01)
and −0.11 WAZ decrement (95% CI, −0.23 to −0.00) at 2 years
of age. Giardia persistence in the first 6 months of life was statistically significantly associated with more than double that decrement in both weight and length at 24 months of age (Table 4).
DISCUSSION

The prospective MAL-ED birth-cohort study provided a unique
opportunity to investigate the complex relationships between
Giardia exposure, micronutrient status, intestinal permeability,
diarrhea, and growth. Giardia detection was common at all sites
and increased in frequency through the second year of life. Major
reductions in Giardia diarrhea incidence when more specific
definitions were used suggest that true Giardia-caused cases of
diarrhea are difficult to identify in settings of high endemicity.
In the absence of molecular typing, evidence of visual clustering
of Giardia detections within children and seasonal patterns limited to first detections suggest that repeated detections can often
represent persistent infections. We identified both hygiene and
environmental risk factors for Giardia infection and confirmed
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Table 3. Associations Between Giardia Detection and Markers of Inflammation and Gut Permeability in All Stool Samples Among 2076 Children in the
MAL-ED Cohort With at Least 1 Biomarker Measurement

Site

LMZ Differencea
(95% CI) (n = 4203)

ALA Differencea
(95% CI) (n = 24 769)

MPO Differencea
(95% CI) (n = 24 769)

NEO Differencea
(95% CI) (n = 24 769)

AGP Differencea
(95% CI) (n = 3550)
−0.44 (−12.01 to 11.14)

BGD

0.29 (0.00 to 0.59)

0.1 (−0.06 to 0.27)

−0.22 (−0.43 to −0.02)

−0.07 (−0.35 to 0.21)

BRF

0.03 (−0.28 to 0.35)

0.00 (−0.22 to 0.23)

−0.18 (−0.46 to 0.09)

−0.20 (−0.42 to 0.02)

INV

0.25 (0.04 to 0.46)

0.00 (−0.12 to 0.13)

−0.12 (−0.23 to −0.01)

−0.08 (−0.2 to 0.03)

3.53 (−10.99 to 18.05)
−1.05 (−8.66 to 6.57)

NEB

0.18 (−0.15 to 0.51)

0.11 (−0.03 to 0.24)

0.01 (−0.14 to 0.16)

−0.10 (−0.21 to 0.01)

−1.05 (−11.62 to 9.51)

PEL

0.23 (0.07 to 0.39)

−0.02 (−0.16 to 0.11)

−0.12 (−0.25 to 0.02)

−0.19 (−0.30 to −0.08)

−5.59 (−15.91 to 4.74)
7.39 (0.35 to 14.43)

PKN

0.19 (0.01 to 0.38)

0.05 (−0.06 to 0.16)

0.00 (−0.11 to 0.10)

0.00 (−0.09 to 0.10)

SAV

0.17 (−0.27 to 0.61)

−0.01 (−0.19 to 0.18)

0.07 (−0.11 to 0.25)

−0.20 (−0.38 to −0.01)

4.45 (−11.05 to 19.94)

TZH

0.01 (−0.42 to 0.44)

0.01 (−0.13 to 0.15)

−0.06 (−0.19 to 0.08)

−0.23 (−0.39 to −0.07)

5.20 (−7.40 to 17.80)

All

0.22 (0.12 to 0.32)

−0.04 (−0.09 to 0.01)

−0.09 (−0.14 to −0.03)

−0.11 (−0.16 to −0.06)

1.83 (−1.82 to 5.47)

Abbreviations: AGP, α-1-acid glycoprotein (mg/dL); BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; CI, confidence interval; INV, Vellore, India; LMZ, urinary lactulose/mannitol excretion ratio z score (BRF cohort was the internal
reference population); ALA, α-1-antitrypsin (log[mg/g]); MPO, myeloperoxidase (log[ng/mL]); NEB, Bhaktapur, Nepal; NEO: neopterin (log[nmol/L]); PEL, Loreto, Peru; PKN, Naushahro Feroze, Pakistan; SAV, Venda, South Africa;
TZH, Haydom, Tanzania.
a
Adjusted for site, age, stool consistency, sex, WAMI (Water, Assets, Maternal Education, Income) score, mother’s age, presence of siblings, water treatment, routine hand-washing after child defecation, use of toilet paper, dirt
floor, ownership of chickens, percent exclusive breastfeeding, and presence of enteroaggregative E coli and/or Campylobacter in stool sample.

that the fecal-oral and waterborne routes both might be important modes of transmission. Host factors, including zinc and
vitamin A deficiencies, might also contribute to Giardia susceptibility, because children with higher micronutrient concentrations had less subsequent Giardia detection. This relationship
might be bidirectional, because Giardia detection from 7 to 15
months of age was also associated with a decrease in retinol
concentration during that period.
In contrast to data from previous reports [8, 9], our longitudinal data did not suggest that Giardia infection was protective
Table 4. Effects of Giardia Detection in Monthly Surveillance Stool
Samples on Weight and Length Attainment at 2 Years of Age Among 1727
Children in the MAL-ED Cohort With Anthropometric Measurements at 2
Years

Exposure
Giardia persistence in first 6 months

n
(N = 1727)
62

WAZ Differencea
(95% CI)

LAZ Differencea,b
(95% CI)

−0.29 (−0.53 to −0.05) −0.29 (−0.64 to 0.07)

Any Giardia detection in first 6
months

173

−0.01 (−0.16 to 0.14)

Giardia persistence in first year

290

−0.04 (−0.16 to 0.09) −0.01 (−0.15 to 0.13)

Any Giardia detection in first year

549

−0.07 (−0.18 to 0.03) −0.07 (−0.18 to 0.03)

Giardia persistence in second year

549

−0.05 (−0.15 to 0.05) −0.09 (−0.19 to 0.01)

Any Giardia detection in second year

976

−0.01 (−0.11 to 0.08) −0.05 (−0.14 to 0.05)

Any Giardia persistence

663

−0.05 (−0.15 to 0.04) −0.07 (−0.17 to 0.03)

1101

−0.02 (−0.12 to 0.08) −0.04 (−0.13 to 0.06)

Any Giardia detection
Any Giardia-related diarrheac
Percent positive surveillance stool
samples (per 38% increased)

557

0.08 (−0.12 to 0.28)

0.07 (−0.04 to 0.19) −0.03 (−0.15 to 0.10)
−0.11 (−0.23 to −0.00) −0.12 (−0.25 to 0.01)

Abbreviations: CI, confidence interval; LAZ, length-for-age z score; WAZ, weight-for-age z score.
a
Adjusted for site, anthropometric measurement at enrollment, sex, WAMI (Water, Assets, Maternal
Education, Income) score, mother’s age, presence of siblings, water treatment, routine hand-washing after
child defecation, use of toilet paper, dirt floor, ownership of chickens, age at stopping exclusive breastfeeding,
and percentage of surveillance stool samples that tested positive for Campylobacter and enteroaggregative E
coli in the first 2 years of life.
b
All LAZ estimates excluded PKN (n = 1478).
c
Also adjusted for Giardia persistence in surveillance stool samples to assess independent effect of diarrhea
with Giardia detection.
d
The difference between the 10th and 90th percentile of cumulative percent positivity across all sites was 38%,
which represents a contrast between high and low Giardia exposure in the context of the MAL-ED cohort.
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against diarrhea across the sites. The protective effect of Giardia
on subsequent acute diarrheal risk was limited to early exposures at the PKN site, which might be explained by the uniquely
high detection rate in the first year of life at this site, environment-specific unidentified biological susceptibility factors,
Giardia strain variability, and coinfection factors. Because the
diagnostic EIA was insensitive to stool consistency, dilution of
Giardia in diarrheal stools does not explain previously reported
inverse associations with diarrhea [4, 7]. In contrast, clearance of
Giardia in diarrheal stools by metronidazole, the most common
antibiotic used for diarrhea treatment in MAL-ED (17% of all
episodes were treated with metronidazole [33]), might contribute to this inverse association.
Even in the absence of diarrheal symptoms, Giardia infection,
especially early persistent infection, was associated with reduced
weight and height attainment at 2 years. This finding was reported
recently from an independent cohort study in Bangladesh [34].
This early impact might be the result of a critical period of susceptibility in which the infant gut and intestinal microbiota are
developing [35, 36]. The increased lactulose/mannitol excretion
ratio associated with Giardia suggests a mechanism through
increased intestinal permeability and malabsorption, components
of environmental enteropathy [18]. Giardia was not associated
with increased markers of intestinal inflammation (ALA, MPO,
or NEO), which suggests that Giardia might disrupt epithelial cells
through pathways different from those of chronic immune activation typical of environmental enteropathy. Given the divergence
between diarrhea and growth outcomes associated with Giardia
infection, diarrhea-independent mechanisms are likely responsible for the growth impact such that physiologic insult occurs without necessary manifestation of diarrhea.
We found that the subset of children with early and persistent Giardia infection experienced a significant disease burden caused by Giardia. However, no association was observed
between Giardia detection and growth in the comprehensive risk

factor models from MAL-ED that compared high and low levels
of Giardia exposures both defined by no detections in the first
6 months (MAL-ED Network Investigators, unpublished data).
Although other determinants might influence growth at later
ages more strongly, targeting Giardia early in life might confer
substantial benefit.
This study was limited by fewer surveillance stool samples
tested in the second year of life when Giardia was most common. In addition, although more sensitive than microscopy,
the EIA has a lower sensitivity than nucleic acid–based detection methods [37, 38]. We also did not use Assemblage typing, which might have helped distinguish persistent infection
from reinfection and explain variability in clinical outcomes
[39, 40]. Last, antihelminthic medications that are active
against Giardia (eg, albendazole or mebendazole) were not
recorded, although they might have been used at the individual level and potentially through mass treatment campaigns.
Despite these limitations, the breadth of data available,
including markers of gut inflammation and permeability,
enabled robust analysis of the effects and potential mechanisms of Giardia infection.
The MAL-ED study enabled a comprehensive description of
Giardia epidemiology in children early in life across 8 diverse
sites. In general, interventions to limit exposure might reduce
Giardia burden better than treatment, because metronidazole
only transiently reduced detection. Interventions to reduce
early exposure (eg, through sustained exclusive breastfeeding)
might have the greatest effect on long-term outcomes, given
increased the susceptibility of children to the effects of Giardia
during their first few months of life.
Supplementary Data

Supplementary materials are available at the Journal of the
Pediatric Infectious Diseases Society online.
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